Published online Sep 18, 2026. doi: 10.5500/wjt.122256
Revised: July 13, 2026
Accepted: August 10, 2026
Published online: September 18, 2026
Processing time: 136 Days and 21.5 Hours
Living donor liver transplantation (LDLT) has become an essential strategy to address the shortage of deceased donor organs in Malaysia. Universiti Malaya Medical Centre (UMMC), the second public institution in the country to establish a liver transplantation program, initiated its adult LDLT program in 2017 and became the first center in the country to successfully perform a living-related adult right lobe LDLT. However, data on donor outcomes from emerging LDLT programs remain limited.
To evaluate donor outcomes and perioperative results of an emerging LDLT pro
This retrospective cohort study included all living donor hepatectomies per
A total of 30 living donor hepatectomies were performed using right lobe, left lobe, and left lateral segment grafts. No donor mortality was observed. Complications included superficial wound infection (n = 4, 13.3%), anesthetic complications (n = 2, 6.7%), pulmonary atelectasis (n = 2, 6.7%), bile leak (n = 1, 3.3%), and gastrointestinal bleeding (n = 1, 3.3%). The median intraoperative blood loss was 500 mL (interquartile range: 400-800 mL), with a transfusion rate of 6.7%. The median length of hospital stay was 10 days. All donors achieved full functional recovery during follow-up.
As an emerging liver transplantation program, UMMC demonstrated favorable donor safety outcomes consistent with published reports from established LDLT centers. Continued refinement of surgical techniques, multidisciplinary perioperative care, and public awareness initiatives will be essential for the sustainable expansion of liver transplantation in Malaysia.
Core Tip: Universiti Malaya Medical Centre established Malaysia’s first structured adult living donor liver transplantation program in a public institution (2017) and has performed 30 living donor hepatectomies using right lobe, left lobe, and left lateral segment grafts. Donor safety is maintained through rigorous three-phase donor evaluation, multidisciplinary selection meetings, standardized open hepatectomy with routine intraoperative cholangiography, and protocol-driven perioperative care. Zero donor mortality, low-incident self-limiting complications, favorable intraoperative blood loss and length of hospital stay, and complete functional recovery indicate living donor liver transplantation can be safe in a low-volume, resource-constrained center when supported by robust clinical governance and evolving institutional expertise.